FIG 2.
Liquid biopsy circulating tumor DNA (ctDNA) molecular profiles of the previously treated rescue cohort that had unknown tissue molecular profiles from primary tissue, with successful plasma-based testing by InVisionSeq (n = 52).
Liquid biopsy circulating tumor DNA (ctDNA) molecular profiles of the previously treated rescue cohort that had unknown tissue molecular profiles from primary tissue, with successful plasma-based testing by InVisionSeq (n = 52).